Furthermore, adiponectin drives fat deposit in small fat cells and subcutaneous adipose tissue but mobilizes visceral fat, supporting its beneficial effect in variety of organ injury, such as nonalcoholic fatty liver disease and fatty heart in obesity and T2DM. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.